The Latest Cardiac and Vascular News
ALISO VIEJO, Calif., March 24, 2025 /PRNewswire/ — Okami Medical announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the SENDERO MAX Delivery Catheter. This milestone expands Okami’s embolization portfolio, which includes the…
Aliso Viejo, CA – October 21, 2024 – Okami Medical today announced the closing of a $32.5M financing led by new investor Vensana Capital and joined by existing investors including U.S. Venture Partners, members of Okami’s board of directors, and other medical device industry veterans. Okami was launched by medical […]
ALISO VIEJO, Calif., Jan. 8, 2024 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced the appointment of Rhonda Robb as President and Chief…
ALISO VIEJO, Calif., June 7, 2022 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LOBO-7 and LOBO-9 Vascular Occluders, the latest addition to the […]
Microcatheter-delivered device provides fast and focal occlusion of peripheral arterial targets ALISO VIEJO, Calif., March 5, 2020 /PRNewswire/ — Okami Medical Inc., a medical device company, announced today the successful completion of the first cases with the LOBOTM Vascular Occlusion System. The first offering in the company’s product portfolio, LOBO-3, recently received 510(k) […]
